Vanguard Global Advisers
RMTI icon

Vanguard Global Advisers’s Rockwell Medical RMTI Stock Holding History

Vanguard Global Advisers’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.83K Hold
1,057
– – ﹤0.01% 3538
2026
Q1 		$9.44K Buy
+1,057
New +$10.5K ﹤0.01% 3484

Other funds holding RMTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Global Advisers's RMTI Position: Q2 2026 in Review

Vanguard Global Advisers held its Rockwell Medical (RMTI) position steady in Q2 2026 at 1,057 shares worth $5.83K. The position accounts for ﹤0.01% of the portfolio, ranked #3538.

Vanguard Global Advisers first reported a position in RMTI in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.44K in Q1 2026. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2026.

  • Vanguard Global Advisers held 1,057 shares of Rockwell Medical worth $5.83K as of Q2 2026.
  • Vanguard Global Advisers left its Rockwell Medical share count unchanged in Q2 2026.
  • Rockwell Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3538 holding.
  • Vanguard Global Advisers first reported a position in Rockwell Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Rockwell Medical position peaked at $9.44K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.